Trident Texofab (BOM:540726) Beta: -0.2987 (As of Jul. 01, 2026)


BOM:540726 Trident Texofab Ltd BOM:540726
63 GF Score
Price ₹36.00
GF Value ₹63.42
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Trident Texofab Beta?

Trident Texofab BOM:540726 -4.23% 63 Beta is -0.2987 as of Jul. 01, 2026. GuruFocus rates BOM:540726 with a GF Score™ of 63/100 and a GF Value™ of ₹63.42 (Possible Value Trap). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-01), Trident Texofab's Beta is -0.2987.


Trident Texofab  (BOM:540726) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Trident Texofab Beta Related Terms


Trident Texofab Beta Historical Data

* Premium members only.

The historical data trend for Trident Texofab's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trident Texofab Beta Chart

Trident Texofab Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.19 -0.48 -1.17 -3.08 -0.48

Trident Texofab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.08 -2.61 -2.97 -2.46 -0.48

Trident Texofab Beta Competitor Comparison

For the Textile Manufacturing subindustry, Trident Texofab's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trident Texofab Beta vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Trident Texofab's Beta distribution charts can be found below:

* The bar in red indicates where Trident Texofab's Beta falls into.


BOM:540726
63GF Score
Trident Texofab Ltd BOM:540726
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trident Texofab Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.2987 mean?
Trident Texofab (BOM:540726) has a Beta of -0.2987 as of Jul. 01, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Trident Texofab and its competitors.
Is Trident Texofab's Beta too high?
Trident Texofab's current Beta is -0.2987. Overall, Trident Texofab has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's Beta compare to competitors?
Trident Texofab's Beta of -0.2987 can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Manufacturing - Apparel & Accessories company?
A good Beta depends on the Manufacturing - Apparel & Accessories industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Trident Texofab and its competitors. Trident Texofab's current Beta is -0.2987. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.42, compared to a current price of ₹36.00 — trading 43.2% below its estimated fair value. The current Beta is -0.2987. Trident Texofab's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current Beta is -0.2987 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trident Texofab (BOM:540726) Overvalued in 2026?

Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued. The current stock price of ₹36.00 is trading 43.2% below its estimated GF Value™ of ₹63.42. GuruFocus considers Trident Texofab to be Possible Value Trap.

Key valuation signals for BOM:540726:

  • Beta: -0.2987
  • GF Value™: ₹63.42 vs. price of ₹36.00 (43.2% below fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Trident Texofab Business Description

Address Ring Road, Nodh-4/1650, Sahara Darwaja, 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Surat, GJ, IND, 395003
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
63GF Score

Get the complete analysis for BOM:540726

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹36.00
Price
₹63.42
GF Value